Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $75
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $80 to $75.
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $80 to $75.
